50 Early-Stage Medical Technology Companies to be Showcased at Medtech Insight's 'Investment In Innovation' Conference, June 14-15, 2005, San Francisco, California.

NEWPORT BEACH, Calif. -- Event to Also Feature Keynote Presentations by Industry Veterans Jay Watkins and Rodney Perkins, M.D.

Medtech Insight has announced that 50 promising young medical technology companies will be presenting at its "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference June 14-15 at The Palace Hotel in San Francisco, that are seeking funding, acquisition, or strategic partnership.

The emerging companies that will be showcased at this event (most presenting at an In3 event for the first time) are developing an array of exciting new technologies in the high-growth market segments of cardiovascular disease diagnosis and treatment, cancer detection and treatment, orthopedics, diabetes and wound management, urology, surgical visualization, and imaging, among many others. They will present to an audience of over 350 senior executives representing the top investment and medical technology firms. The forum will include focused 10-minute presentations by a senior executive from each presenting company, followed immediately by one-on-one meetings with company representatives in private breakout rooms.

Companies confirmed to date to present in San Francisco include (with more being added): Advanced BioSensors, Aeres Medical, Affinergy, Alpine Biomed, Anpa Medical, Aperio Technologies, Apogee Biodimensions, Aqueduct Medical, Arbor Surgical Technologies, Bioheart, Biomarker Technologies, Cardiac Power, CardioFocus, CoolTouch, FlowCardia, Grant Life Sciences, Hoana Medical, Intelligent Clothing, Interventional Imaging, IYIA Technologies, LabNow, MedicalCV, Micro Vision Systems, Minnow Medical, MINVASYS, Mitralign, Nano Interface Technology, Neural Interventional Technologies, NeuroVision, PlaCor, QuiCare, Remote Clinical Solutions, Smart Medical Technologies, Spine Motion, SPL Development, TechniScan, Vascular Designs, Viking Systems, Visionsense, Xilas Medical, and Xillix Technologies. Check the Medtech Insight Web site at http://www.medtechinsight.com/in3-14.html for a regularly updated listing of presenters, their technology descriptions, and other event details.

The event will be kicked off by keynote presentations by industry veterans Jay Watkins, managing director at De Novo Ventures, who will speak at the event on "Medical Technology Investing: Perspectives of a VC," and Rodney Perkins, M.D., founder, chairman & CEO of Sound ID, who will discuss "Lessons Learned from a Serial Entrepreneur." Ronald Podraza, CEO of Reimbursement Principles, will also speak at the meeting about "Reimbursement Issues Throughout the Device Lifecycle," and Robin M. Silva, partner at Dorsey & Whitney, will present on "Making Your IP Work for You: What Every Medtech Company Needs to Know About Starting, Managing, and Leveraging Your IP Portfolios." In addition, the conference will feature two informative and interactive industry panel discussions; please see the conference agenda at this link for more information: http://www.medtechinsight.com/Agenda-in3-14.html.

This event will be attended by the biggest dealmakers in the device industry, including these companies, among many others: Abbott Laboratories, Advanced Technology Ventures, Aubrey Group, Bay City Capital Partners, Boston Scientific, C.R. Bard, Cardinal Health, Datascope, Duane Morris LLP, Earlybird Ventures, Edwards Lifesciences, Ethicon, Ethicon Endo-Surgery, Guidant, Johnson & Johnson, Kaiser Permanente Ventures, Kaneka America, KeyBanc Capital Markets, Kimberly-Clark, Kobayashi Pharmaceuticals of America, Krauth Medical, MedFocus Fund, Medtronic, Montgomery & Company, Musculoskeletal Transplant Foundation, Nellcor Puritan Bennett, Nixon Peabody, Olympus, Palo Alto Capital Partners, Pequot Capital, Philips Medical, St. Jude Medical, Stryker, Synergy Partners International, Terumo, and Wilson Sonsini Goodrich & Rosati, just to name a few.

Medtech Insight and their parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for senior executives in the medical device, diagnostics, biotech, pharmaceutical and investment communities to preview promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry.

To register to attend the In3 San Francisco event, call Kristy Grimes of Medtech Insight at 480-985-9512, e-mail [e-mail], or register on the Medtech Insight Web site at http://www.medtechinsight.com/in3-14.html.

Co-sponsors for In3 San Francisco include AdvaMed, Battelle, Business Wire, Dorsey & Whitney LLP, Houlihan Lokey Howard & Zukin, Medmarc and The Hartford, PPD Medical Device, Reimbursement Principles, Ronald Trahan Associates, Teledyne Microelectronic Technologies, The MedTech Group, and Underwriters Laboratories.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.